ILC Therapeutics Ltd
2 known investors
ILC Therapeutics is a biotechnology company developing hybrid interferon therapeutics, including its Alfacyte product, based on an interferon platform. The company operates in the drug development and pharmaceutical industry.
Founders & leadership
OM
Owain MillingtonCEO
Investors · 2
Companies House · registry record
View on Companies House ↗Confirmation statement overdue
- Registered name
- ILC THERAPEUTICS LTD
- Company number
- SC426667
- Status
- Active
- Company type
- Private limited company
- Incorporated
- 21 Jun 2012
- Registered office
- Suite 2, Ground Floor Orchard Brae House, 30 Queensferry Road, Edinburgh, EH4 2HS
- Nature of business (SIC)
- 72110 — Research and experimental development on biotechnology
- Previous names
- ALFACYTE LIMITED (2012–2019)
- Accounts
- last made up to 30 Jun 2025 · next due 31 Mar 2027
- Confirmation statement
- last made up to 13 Jul 2025 · next due 27 Jul 2026
Current officers · 7
- Mbm Secretarial Services Limited — corporate secretary, appointed 3 Feb 2023
- Peter James Jonathan Bains — director, appointed 12 May 2021
- Christopher David Brinsmead — director, appointed 1 Sept 2021
- Kevin Gawn Grainger — director, appointed 15 Jul 2015
- David Harrison — director, appointed 1 Sept 2021
- Robert Kopple — director, appointed 2 Sept 2021
- Owain Richard Millington — director, appointed 1 Jul 2024
Source: Companies House public register · retrieved 5 Aug 2026. Contains public sector information licensed under the Open Government Licence v3.0.